title: Les syndromes paranéoplasiques.
abstract: Paraneoplastic syndromes affecting the nervous system are rare but devastating complications of systemic cancer. The neurologic disorder usually precedes identification of the cancer and can affect any portion of the nervous system including cerebral cortex, cerebellum, spinal cord, peripheral nerves, neuromuscular junction or muscle. A single area or cell type of the nervous system may be affected or the entire neuraxis may be involved. The pathogenesis of paraneoplastic syndromes involving the nervous system is believed to be immune-mediated: the current hypothesis is that antigens usually expressed only in neurons are expressed in a cancer; the immune system recognizes the antigen in the cancer as foreign and mounts an immune response that slows the growth of the tumor but damages the nervous system. The diagnosis of a paraneoplastic syndrome is made either by identifying a small cancer in a patient with a neurologic disorder of unknown etiology or by identifying paraneoplastic autoantibodies in the serum of patients. The treatment involves identification and treatment of the causal cancer and immunosuppression to suppress both the humoral and cellular immune response.
authors.affiliation: Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. posnerj@mskcc.org
authors.forename: J B
authors.initials: JB
authors.lastname: Posner
mesh_terms: D000818:Animals; D006801:Humans; D007165:Immunosuppression Therapy; D010257:Paraneoplastic Syndromes / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D011379:Prognosis